SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
BioMidwest
Humanetics Corporation Presents at the MedInvest Oncology Investor Conference
December 16, 2022
 · 
2 min read
Drug Development
Humanetics Corporation Publishes Phase 1 Trial Results for BIO 300 Oral Powder
November 15, 2022
 · 
2 min read
BioMidwest
Humanetics Corporation Presents at the 68th Annual International Radiation Research Society Meeting
October 25, 2022
 · 
2 min read
FDA
Humanetics Receives FDA Clearance to Begin Studies in Second Oncology Indication
October 5, 2022
 · 
2 min read
Business
Thomas F. Jasper Joins Board at Humanetics
September 22, 2022
 · 
3 min read
BioMidwest
Jake R. Nunn Joins Board at Humanetics
August 9, 2022
 · 
3 min read
BioMidwest
Humanetics Announces That ATD-LabTech GmbH Is Joining the Humanetics Group
July 29, 2022
 · 
2 min read
BioMidwest
BIO 300 Pharmacokinetics Studies Published
July 27, 2022
 · 
2 min read
Drug Development
AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study
July 12, 2022
 · 
3 min read
BioMidwest
U.S. Department of Defense Awards $5.1 Million to Humanetics Corporation for Continued Development of Radiation Countermeasure
June 21, 2022
 · 
2 min read
Load More
JOBS